The peptide problem: Hype is outrunning the evidence The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step US FDA to convene expert panel to review wider access to some peptides Reuters Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Compounded "semaglutide" is not FDA approved semaglutide.com Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link